Contrast‐enhanced CT‐based radiomic analysis for determining the response to anti‐programmed death‐1 therapy in esophageal squamous cell carcinoma patients: A pilot study

BACKGROUND: In view of the fact that radiomics features have been reported as predictors of immunotherapy to various cancers, this study aimed to develop a prediction model to determine the response to anti‐programmed death‐1 (anti‐PD‐1) therapy in esophageal squamous cell carcinoma (ESCC) patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Qinzhu, Huang, Haofan, Zhang, Guizhi, Weng, Nuoqing, Ou, Zhenkai, Sun, Meili, Luo, Huixing, Zhou, Xuhui, Gao, Yi, Wu, Xiaobin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665784/
https://www.ncbi.nlm.nih.gov/pubmed/37743537
http://dx.doi.org/10.1111/1759-7714.15117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10665784/
https://www.ncbi.nlm.nih.gov/pubmed/37743537
http://dx.doi.org/10.1111/1759-7714.15117

Ejemplares similares